A Phase 2 Study of REOLYSIN in Combination With Gemcitabine for Patients With Advanced Pancreatic Adenocarcinoma.
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Pelareorep (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Oncolytics Biotech
- 06 Jul 2015 According to Oncolytics Biotech media release, final data has been presented at the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer.
- 06 Jul 2015 Results published in Oncolytics Biotech Media Release.
- 29 May 2015 Results of the correlation of outcomes with skeletal muscle changes were presented at the 51st Annual Meeting of the American Society of Clinical Oncology.